TP53BP1 and cancer: Thus, we believe that chromosomal (hyper-)instability may need to be restrained in cancers, (e.g. by 53BP1-mediated pathway) otherwise the adverse effects such as chromatid intertwining and unwanted rearrangements may hinder tumour survival fitness.